Wells Fargo
FBT icon

Wells Fargo’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Wells Fargo’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-600
Closed -$79K – 7538
2022
Q3 		$79K Buy
+600
New +$84.2K ﹤0.01% 4733

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Wells Fargo's FBT Position: Q2 2026 in Review

Wells Fargo increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4.3% in Q2 2026, buying an estimated $3.9M and bringing the position to 444,334 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #641.

Wells Fargo first reported a position in FBT in Q2 2013 and has held it in 53 quarters since. The position peaked at $254M in Q1 2015. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Wells Fargo held 444,334 shares of First Trust NYSE Arca Biotechnology Index Fund worth $110M as of Q2 2026.
  • Wells Fargo bought 18,121 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.9M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #641 holding.
  • Wells Fargo first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's First Trust NYSE Arca Biotechnology Index Fund position peaked at $254M in Q1 2015.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.